Literature DB >> 24262682

Premorbid adjustment and schizophrenia in individuals with 22q11.2 deletion syndrome.

Tracy Yuen1, Eva W C Chow, Candice K Silversides, Anne S Bassett.   

Abstract

UNLABELLED: The literature on idiopathic schizophrenia has consistently reported that poor premorbid functioning precedes onset of psychosis. Individuals with 22q11.2 deletion syndrome (22q11.2DS) are at heightened risk of developing schizophrenia. The present study examined the relationship between adult-onset schizophrenia and social and academic functioning across childhood and early adolescent development in 22q11.2DS.
METHOD: Premorbid adjustment in social and academic domains during childhood (ages 5-11 years) and early adolescence (ages 12-15 years) of 103 adults with 22q11.2DS was assessed using the Premorbid Adjustment Scale (PAS). Linear mixed-models were used to compare PAS scores between the 43 subjects who later developed schizophrenia and the 60 subjects who did not.
RESULTS: Social functioning and academic functioning deteriorated from childhood to early adolescence among those who later developed schizophrenia compared to stable functioning, on average, in those who did not later develop a psychotic disorder. Those who developed schizophrenia had significantly higher PAS scores (indicating poorer functioning) in social (β=0.118, 95% CI: 0.046-0.189) and academic (β=0.072, 95% CI: 0.015-0.129) domains between childhood and early adolescence, independent of the presence of intellectual disability. The two groups had similar PAS scores during childhood.
CONCLUSION: Consistent with the literature on idiopathic schizophrenia, deterioration in social and academic functioning between childhood and early adolescence preceded onset of schizophrenia in this cohort of 22q11.2DS patients, regardless of functioning at baseline. These findings suggest that monitoring for changes in functioning, in addition to emergence of typical symptoms, may help to prevent delays in diagnosis and treatment of major psychotic illness in 22q11.2DS.
© 2013.

Entities:  

Keywords:  22q11.2 deletion syndrome; Premorbid adjustment; Schizophrenia

Mesh:

Year:  2013        PMID: 24262682     DOI: 10.1016/j.schres.2013.10.041

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  12 in total

1.  Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.

Authors:  Kevin M Antshel; Wanda Fremont; Seetha Ramanathan; Wendy R Kates
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

2.  Childhood Predictors of Young Adult Social Functioning in 22q11.2 Deletion Syndrome.

Authors:  Kayla E Wagner; Wendy R Kates; Wanda Fremont; Kevin M Antshel
Journal:  J Autism Dev Disord       Date:  2017-08

3.  Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome.

Authors:  Maude Schneider; Marco Armando; Maria Pontillo; Stefano Vicari; Martin Debbané; Frauke Schultze-Lutter; Stephan Eliez
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

4.  Neuropsychiatric aspects of 22q11.2 deletion syndrome: considerations in the prenatal setting.

Authors:  Anne S Bassett; Gregory Costain; Christian R Marshall
Journal:  Prenat Diagn       Date:  2016-11-14       Impact factor: 3.050

5.  Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.

Authors:  Jacob A S Vorstman; Elemi J Breetvelt; Sasja N Duijff; Stephan Eliez; Maude Schneider; Maria Jalbrzikowski; Marco Armando; Stefano Vicari; Vandana Shashi; Stephen R Hooper; Eva W C Chow; Wai Lun Alan Fung; Nancy J Butcher; Donald A Young; Donna M McDonald-McGinn; Annick Vogels; Therese van Amelsvoort; Doron Gothelf; Ronnie Weinberger; Abraham Weizman; Petra W J Klaassen; Sanne Koops; Wendy R Kates; Kevin M Antshel; Tony J Simon; Opal Y Ousley; Ann Swillen; Raquel E Gur; Carrie E Bearden; René S Kahn; Anne S Bassett
Journal:  JAMA Psychiatry       Date:  2015-04       Impact factor: 21.596

Review 6.  Practical guidelines for managing adults with 22q11.2 deletion syndrome.

Authors:  Wai Lun Alan Fung; Nancy J Butcher; Gregory Costain; Danielle M Andrade; Erik Boot; Eva W C Chow; Brian Chung; Cheryl Cytrynbaum; Hanna Faghfoury; Leona Fishman; Sixto García-Miñaúr; Susan George; Anthony E Lang; Gabriela Repetto; Andrea Shugar; Candice Silversides; Ann Swillen; Therese van Amelsvoort; Donna M McDonald-McGinn; Anne S Bassett
Journal:  Genet Med       Date:  2015-01-08       Impact factor: 8.822

Review 7.  A cross-comparison of cognitive ability across 8 genomic disorders.

Authors:  Michael Mortillo; Jennifer G Mulle
Journal:  Curr Opin Genet Dev       Date:  2021-05-31       Impact factor: 4.665

8.  Failure to thrive as presentation in a patient with 22q11.2 microdeletion.

Authors:  Grazia Bossi; Chiara Gertosio; Cristina Meazza; Giovanni Farello; Mauro Bozzola
Journal:  Ital J Pediatr       Date:  2016-02-11       Impact factor: 2.638

9.  Associations between social cognition, skills, and function and subclinical negative and positive symptoms in 22q11.2 deletion syndrome.

Authors:  A Vangkilde; J R M Jepsen; H Schmock; C Olesen; S Arnarsdóttir; W F C Baaré; K J Plessen; M Didriksen; H R Siebner; T Werge; L Olsen
Journal:  J Neurodev Disord       Date:  2016-11-16       Impact factor: 4.025

Review 10.  Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.

Authors:  Maude Schneider; Martin Debbané; Anne S Bassett; Eva W C Chow; Wai Lun Alan Fung; Marianne van den Bree; Michael Owen; Kieran C Murphy; Maria Niarchou; Wendy R Kates; Kevin M Antshel; Wanda Fremont; Donna M McDonald-McGinn; Raquel E Gur; Elaine H Zackai; Jacob Vorstman; Sasja N Duijff; Petra W J Klaassen; Ann Swillen; Doron Gothelf; Tamar Green; Abraham Weizman; Therese Van Amelsvoort; Laurens Evers; Erik Boot; Vandana Shashi; Stephen R Hooper; Carrie E Bearden; Maria Jalbrzikowski; Marco Armando; Stefano Vicari; Declan G Murphy; Opal Ousley; Linda E Campbell; Tony J Simon; Stephan Eliez
Journal:  Am J Psychiatry       Date:  2014-06       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.